Cobblestone Capital Advisors Has Decreased Its Bank Amer (BAC) Holding; Highvista Strategies …

… 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop; …

The Medicines Company (NASDAQ:MDCO) Logo

Highvista Strategies Llc decreased Medicines Co (MDCO) stake by 12.64% reported in 2018Q4 SEC filing. Highvista Strategies Llc sold 33,900 shares as Medicines Co (MDCO)’s stock rose 20.76%. The Highvista Strategies Llc holds 234,340 shares with $4.49 million value, down from 268,240 last quarter. Medicines Co now has $2.35 billion valuation. The stock decreased 0.47% or $0.15 during the last trading session, reaching $31.8. About 960,571 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 22.18% since May 2, 2018 and is downtrending. It has underperformed by 26.55% the S&P500. Some Historical MDCO News: 08/03/2018 – REG-DURA VERMEER AND HEIJMANS IN BUILDING CONSORTIUM FOR EUROPEAN MEDICINES AGENCY NEW-BUILD PROJECT; 28/03/2018 – European Medicines Agency (EMA) Accepts BioMarin’s Marketing Application for Pegvaliase MAA for Treatment of Phenylketonuria (P; 03/04/2018 – ASTRAZENECA PLC – CO AND MERCK ANNOUNCES EUROPEAN MEDICINES AGENCY HAS VALIDATED FOR REVIEW MARKETING AUTHORISATION APPLICATION FOR LYNPARZA (OLAPARIB); 22/03/2018 – CHINA NATIONAL MEDICINES 600511.SS SAYS 2017 NET PROFIT UP 15.3 PCT Y/Y; 13/03/2018 – CSL CEO Paul Perreault Calls on Industry to Improve Patients’ Access to Medicines; 03/04/2018 – REGENERON PHARMACEUTICALS INC REGN.O – EUROPEAN MEDICINES AGENCY HAS ACCEPTED FOR REVIEW MARKETING AUTHORIZATION APPLICATION (MAA) FOR CEMIPLIMAB; 28/03/2018 – KINGWORLD MEDICINES GROUP LTD – FY REVENUE DECREASED BY 2.1% TO RMB1.03 BLN; 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop; 07/05/2018 – Medicines Co: Phase III Trials of Inclisiran Progressing as Planned With No Material Safety Observations; 16/04/2018 – Synlogic: Data Highlight Application of Synthetic Biotic Medicines for Potential Treatment of Variety of Solid Tumors

Cobblestone Capital Advisors Llc decreased Bank Amer Corp (BAC) stake by 3.16% reported in 2018Q4 SEC filing. Cobblestone Capital Advisors Llc sold 14,004 shares as Bank Amer Corp (BAC)’s stock rose 2.11%. The Cobblestone Capital Advisors Llc holds 428,497 shares with $10.56 million value, down from 442,501 last quarter. Bank Amer Corp now has $287.72B valuation. The stock decreased 1.05% or $0.32 during the last trading session, reaching $30.26. About 55.06M shares traded. Bank of America Corporation (NYSE:BAC) has declined 7.78% since May 2, 2018 and is downtrending. It has underperformed by 12.15% the S&P500. Some Historical BAC News: 04/05/2018 – NY Bizjournal: Bank of America names new entertainment industries group leader; 15/05/2018 – DELTA CFO COMMENTS AT BANK OF AMERICA/MERRILL LYNCH CONFERENCE; 04/05/2018 – Emerging market “tremors” after U.S. yield surge, small equity outflow- BAML data; 14/05/2018 – Premier Presenting at Bank of America Conference Tomorrow; 28/03/2018 – GM CEO MARY BARRA SPEAKS AT BANK OF AMERICA AUTO SUMMIT; 06/04/2018 – INSPIRE MEDICAL SYSTEMS SAYS BOFA MERRILL LYNCH, GOLDMAN SACHS & CO LLC ARE AMONG UNDERWRITERS TO IPO; 27/04/2018 – BOFA CEO BRIAN MOYNIHAN SPEAKS AT MIT SLOAN CONFERENCE IN NYC; 05/03/2018 – Consumer discretionary overtook tech as the most crowded sector last month, data from Bank of America Merrill Lynch shows; 07/05/2018 – Bank of America says Nvidia’s product leadership in the gaming business makes for a strong “buy” case; 10/05/2018 – Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch Health Care Conference 2018

Among 6 analysts covering Bank of America (NYSE:BAC), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Bank of America had 11 analyst reports since December 7, 2018 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, January 9 by UBS. On Wednesday, December 12 the stock rating was downgraded by Wood to “Market Perform”. The rating was maintained by Oppenheimer with “Outperform” on Tuesday, March 26. The stock of Bank of America Corporation (NYSE:BAC) has “Buy” rating given on Tuesday, February 19 by Credit Suisse. As per Friday, December 7, the company rating was maintained by Credit Suisse. Jefferies downgraded Bank of America Corporation (NYSE:BAC) on Wednesday, April 17 to “Hold” rating. The rating was maintained by BMO Capital Markets with “Market Perform” on Wednesday, April 17.

Cobblestone Capital Advisors Llc increased Ishares Tr (MBB) stake by 41,745 shares to 49,547 valued at $5.19M in 2018Q4. It also upped Spdr Index Shs Fds (CWI) stake by 295,124 shares and now owns 572,010 shares. Ishares Tr (IXUS) was raised too.

Investors sentiment decreased to 0.83 in 2018 Q4. Its down 0.01, from 0.84 in 2018Q3. It is negative, as 107 investors sold BAC shares while 616 reduced holdings. 124 funds opened positions while 475 raised stakes. 6.44 billion shares or 1.20% more from 6.37 billion shares in 2018Q3 were reported. Atwood And Palmer owns 15,092 shares. Evercore Wealth Mngmt Limited Liability Co reported 0.04% in Bank of America Corporation (NYSE:BAC). Zwj Invest Counsel invested in 0.27% or 114,864 shares. Kornitzer Ks has invested 0.03% in Bank of America Corporation (NYSE:BAC). Fil Ltd holds 0.17% in Bank of America Corporation (NYSE:BAC) or 3.92 million shares. New Mexico Educational Retirement Board accumulated 790,754 shares. Institute For Wealth Mgmt Ltd Liability Co has invested 1.36% in Bank of America Corporation (NYSE:BAC). California-based Poplar Forest Capital Lc has invested 4.29% in Bank of America Corporation (NYSE:BAC). Cliftonlarsonallen Wealth Lc holds 88,362 shares. Tru Of Virginia Va reported 30,384 shares. Advisory Rech Incorporated reported 612,468 shares or 0.32% of all its holdings. Smithfield Tru stated it has 0.08% of its portfolio in Bank of America Corporation (NYSE:BAC). Qci Asset Management Inc Ny owns 759,795 shares. Tiaa Cref Llc reported 38.70M shares stake. Moreover, Roanoke Asset Mngmt Corporation New York has 2.65% invested in Bank of America Corporation (NYSE:BAC).

More notable recent Bank of America Corporation (NYSE:BAC) news were published by: Investorplace.com which released: “5 Top Stock Trades for Tuesday: GOOGL, BAC, ADBE, JNJ – Investorplace.com” on April 29, 2019, also Benzinga.com with their article: “Bank Of America Reports Record Q1 Earnings (NYSE:BAC) – Benzinga” published on April 16, 2019, Investorplace.com published: “Targeting Bank of America for More Option Income – Investorplace.com” on May 01, 2019. More interesting news about Bank of America Corporation (NYSE:BAC) were released by: Investorplace.com and their article: “Is This Breakout The Time To Be Buying Bank of America Stock? – Investorplace.com” published on May 02, 2019 as well as Investorplace.com‘s news article titled: “9 Hot Stocks to Buy Now – Investorplace.com” with publication date: May 01, 2019.

Among 5 analysts covering Medicines Co (NASDAQ:MDCO), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Medicines Co had 10 analyst reports since December 13, 2018 according to SRatingsIntel. The rating was maintained by FBR Capital with “Buy” on Wednesday, February 27. Goldman Sachs upgraded the stock to “Buy” rating in Friday, April 26 report. The rating was maintained by Cowen & Co on Wednesday, February 27 with “Buy”. FBR Capital maintained the stock with “Buy” rating in Monday, March 18 report.

Investors sentiment increased to 1.76 in 2018 Q4. Its up 0.68, from 1.08 in 2018Q3. It increased, as 23 investors sold MDCO shares while 36 reduced holdings. 38 funds opened positions while 66 raised stakes. 89.79 million shares or 2.48% more from 87.62 million shares in 2018Q3 were reported. Wellington Mngmt Gp Ltd Liability Partnership, Massachusetts-based fund reported 10.30M shares. Ameritas Investment Prtn Inc reported 5,811 shares. Wolverine Asset Mngmt Ltd has 0% invested in The Medicines Company (NASDAQ:MDCO) for 3,513 shares. The California-based California Public Employees Retirement Systems has invested 0% in The Medicines Company (NASDAQ:MDCO). Credit Suisse Ag owns 56,075 shares. 101,235 are owned by Arizona State Retirement System. 20,403 are owned by Daiwa Securities Group Inc. 14,753 were reported by Cim Investment Mangement. Commonwealth Of Pennsylvania Pub School Empls Retrmt accumulated 22,541 shares or 0.01% of the stock. Pictet Asset Management Limited owns 65,100 shares. Moreover, Fosun Intll has 0.04% invested in The Medicines Company (NASDAQ:MDCO) for 34,000 shares. Pinebridge Invs LP holds 0.02% in The Medicines Company (NASDAQ:MDCO) or 54,275 shares. Parallax Volatility Advisers Ltd Partnership holds 0% or 7,937 shares. Jpmorgan Chase & Com stated it has 0% in The Medicines Company (NASDAQ:MDCO). Thrivent Financial For Lutherans reported 46,387 shares stake.

The Medicines Company (NASDAQ:MDCO) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Waddell & Reed Financial Maintains Stake in Duke Energy New (DUK); Novo (NVO) Holder …

Waddell & Reed Financial Inc increased its stake in Duke Energy Corp New (DUK) by 206.52% based on its latest 2018Q4 regulatory filing with the …

Duke Energy Corporation (NYSE:DUK) Logo

Highvista Strategies Llc decreased its stake in Novo (NVO) by 22.16% based on its latest 2018Q4 regulatory filing with the SEC. Highvista Strategies Llc sold 12,100 shares as the company’s stock rose 6.98% with the market. The hedge fund held 42,500 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $1.96 million, down from 54,600 at the end of the previous reported quarter. Highvista Strategies Llc who had been investing in Novo for a number of months, seems to be less bullish one the $116.65 billion market cap company. The stock increased 1.03% or $0.5 during the last trading session, reaching $48.93. About 986,546 shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 2.11% since April 28, 2018 and is downtrending. It has underperformed by 6.48% the S&P500. Some Historical NVO News: 29/05/2018 – OMX Copenhagen 20 Falls 1.7% to 967.39; Novo Nordisk Leads; 04/05/2018 – Novo Nordisk’s Saxenda Sales Rise; Obesity Market Up 1%; 16/04/2018 – Vivus’s Qsymia Falls After 2-Wk Rise, Saxenda Declines: Obesity; 23/05/2018 – San Diego-based Epigen Biosciences enters a collaboration to license its LPA1 Receptor small molecule program to Novo Nordisk A; 26/03/2018 – NOVO NORDISK A/S: FDA OKS INCLUSION OF DATA ON CARDIOVASCULAR; 09/05/2018 – Global Non-insulin Diabetes Therapeutics Market Forecasts to 2022 – Key Players are AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi – ResearchAndMarkets.com; 16/05/2018 – G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting; 11/04/2018 – NOVO NORDISK LAUNCHES REBINYN FOR HEMOPHILIA B IN CANADA; 10/04/2018 – Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizures; 04/05/2018 – NOVO NORDISK – TRANSACTION PART OF CO’S 2018 SHARE REPURCHASE PROGRAMME OF UP TO DKK 14.0 BLN TO BE EXECUTED DURING 12 MONTHS PERIOD FROM 1 FEBRUARY 2018

Waddell & Reed Financial Inc increased its stake in Duke Energy Corp New (DUK) by 206.52% based on its latest 2018Q4 regulatory filing with the SEC. Waddell & Reed Financial Inc bought 278,800 shares as the company’s stock rose 2.60% with the market. The institutional investor held 413,800 shares of the power generation company at the end of 2018Q4, valued at $35.71M, up from 135,000 at the end of the previous reported quarter. Waddell & Reed Financial Inc who had been investing in Duke Energy Corp New for a number of months, seems to be bullish on the $65.73B market cap company. The stock decreased 0.14% or $0.13 during the last trading session, reaching $90.32. About 1.88M shares traded. Duke Energy Corporation (NYSE:DUK) has risen 18.95% since April 28, 2018 and is uptrending. It has outperformed by 14.58% the S&P500. Some Historical DUK News: 10/05/2018 – Duke Energy 1Q Adj EPS $1.28; 22/03/2018 – CORRECTED-BREAKINGVIEWS-Duke Energy draws power from climate activism; 10/05/2018 – DUKE ENERGY 1Q EARNINGS CALL CONCLUDES; 11/05/2018 – DUKE CUTS CATAWBA 2 REACTOR TO 65% POWER FROM 100%: NRC; 26/04/2018 – Grange Insurance Names Damon Porter Chief Human Resources Officer; 02/04/2018 – DUKE ENERGY WILL RETIRE CRYSTAL RIVER COAL-FIRED UNITS 1, 2; 08/03/2018 – Piedmont Natural Gas reminds its customers and communities to be vigilant about avoiding utility scams; 16/04/2018 – Duke Energy’s $62 M Solar Rebate Program Approved for North Carolina Residential, Business and Nonprofit Customers; 21/05/2018 – DUKE RAISES OCONEE 3 REACTOR TO 100% POWER FROM 0% FRIDAY: NRC; 18/04/2018 – DUKE’S BRUNSWICK 2 NUCLEAR REACTOR CUT TO 85% FROM 100%: NRC

More notable recent Duke Energy Corporation (NYSE:DUK) news were published by: Seekingalpha.com which released: “Duke Energy Corporation: This 5.625% Baby Bond Has Begun Trading On The NYSE – Seeking Alpha” on September 24, 2018, also Seekingalpha.com with their article: “Duke Energy downgraded at BAML on valuation, Atlantic Coast pipeline risks – Seeking Alpha” published on January 09, 2019, Bizjournals.com published: “Former chief exec of Duke Energy, Progress takes CEO job at bankrupt PG&E – Charlotte Business Journal” on April 04, 2019. More interesting news about Duke Energy Corporation (NYSE:DUK) were released by: Prnewswire.com and their article: “Arbor Day Foundation recognizes Duke Energy Florida as Tree Line USA utility for 13th consecutive year – PRNewswire” published on April 26, 2019 as well as Prnewswire.com‘s news article titled: “Duke Energy enters into definitive agreement to sell minority interest in its commercial renewable energy portfolio to John Hancock – PRNewswire” with publication date: April 24, 2019.

Investors sentiment increased to 1.01 in Q4 2018. Its up 0.10, from 0.91 in 2018Q3. It is positive, as 53 investors sold DUK shares while 361 reduced holdings. 102 funds opened positions while 317 raised stakes. 437.22 million shares or 7.02% more from 408.54 million shares in 2018Q3 were reported. Adirondack Tru invested in 1,282 shares. Windward Capital Mgmt Com Ca, California-based fund reported 30,337 shares. Boyer Corporon Wealth Limited Liability Co has invested 2.41% in Duke Energy Corporation (NYSE:DUK). Pub Sector Pension Board holds 0.03% of its portfolio in Duke Energy Corporation (NYSE:DUK) for 36,735 shares. The Illinois-based Optimum Invest has invested 0.24% in Duke Energy Corporation (NYSE:DUK). Cornerstone Incorporated accumulated 61,119 shares. Smithfield Tru invested in 0.01% or 1,412 shares. Smart Portfolios Ltd Llc invested in 0.07% or 1,035 shares. Wealthquest Corp accumulated 6,228 shares. Evermay Wealth Mgmt stated it has 0.33% in Duke Energy Corporation (NYSE:DUK). Linscomb & Williams reported 0.47% of its portfolio in Duke Energy Corporation (NYSE:DUK). California Pub Employees Retirement Sys invested in 0.44% or 3.67M shares. Guardian Life Of America accumulated 0.03% or 2,017 shares. Boston Research & Mgmt Inc holds 0.32% of its portfolio in Duke Energy Corporation (NYSE:DUK) for 7,859 shares. Boltwood Capital Mngmt owns 0.35% invested in Duke Energy Corporation (NYSE:DUK) for 5,945 shares.

Waddell & Reed Financial Inc, which manages about $14.31 billion and $35.31 billion US Long portfolio, decreased its stake in Continental Resources Inc (NYSE:CLR) by 13,428 shares to 678,327 shares, valued at $27.26 million in 2018Q4, according to the filing. It also reduced its holding in Magellan Midstream Prtnrs Lp (NYSE:MMP) by 17,302 shares in the quarter, leaving it with 199,548 shares, and cut its stake in Edwards Lifesciences Corp (NYSE:EW).

More notable recent Novo Nordisk A/S (NYSE:NVO) news were published by: Seekingalpha.com which released: “Novo Nordisk: Diabetes Care Driving Current And Forward Results – Seeking Alpha” on November 04, 2018, also Seekingalpha.com with their article: “Novo Nordisk: Obesity Crisis Continues To Get Worse – Buy The Stock Today – Seeking Alpha” published on June 03, 2018, Seekingalpha.com published: “Novo Nordisk A/S 2018 Q3 – Results – Earnings Call Slides – Seeking Alpha” on November 01, 2018. More interesting news about Novo Nordisk A/S (NYSE:NVO) were released by: Seekingalpha.com and their article: “Novo Nordisk’s Growth Initiatives May Make The Stock Sweet Again – Seeking Alpha” published on February 26, 2019 as well as Seekingalpha.com‘s news article titled: “Novo Nordisk: An Objective Analysis – Seeking Alpha” with publication date: May 08, 2018.

Duke Energy Corporation (NYSE:DUK) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

As Medicines Co (MDCO) Stock Price Rose, Shareholder Highvista Strategies Trimmed Position …

… Disease (SCD); 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism …

The Medicines Company (NASDAQ:MDCO) Logo

Highvista Strategies Llc decreased its stake in Medicines Co (MDCO) by 12.64% based on its latest 2018Q4 regulatory filing with the SEC. Highvista Strategies Llc sold 33,900 shares as the company’s stock rose 20.76% with the market. The hedge fund held 234,340 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $4.49M, down from 268,240 at the end of the previous reported quarter. Highvista Strategies Llc who had been investing in Medicines Co for a number of months, seems to be less bullish one the $2.08B market cap company. The stock decreased 0.21% or $0.06 during the last trading session, reaching $28.19. About 568,999 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 22.18% since April 16, 2018 and is downtrending. It has underperformed by 26.55% the S&P500. Some Historical MDCO News: 03/04/2018 – Sancilio Pharmaceuticals Company Announces Altemia™ Receives Orphan Drug Designation from the European Medicines Agency for the Treatment of Pediatric Patients with Sickle Cell Disease (SCD); 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop; 02/05/2018 – The Medicines Patent Pool Adds New Suppliers from South Africa and South Korea to its Growing Generic Manufacturing Network; 03/04/2018 – ASTRAZENECA PLC – CO AND MERCK ANNOUNCES EUROPEAN MEDICINES AGENCY HAS VALIDATED FOR REVIEW MARKETING AUTHORISATION APPLICATION FOR LYNPARZA (OLAPARIB); 08/03/2018 – REG-DURA VERMEER AND HEIJMANS IN BUILDING CONSORTIUM FOR EUROPEAN MEDICINES AGENCY NEW-BUILD PROJECT; 16/04/2018 – Melinta Therapeutics to Present Detailed Results from Vabomere TANGO II Trial as well as New In Vitro and In Vivo Findings from; 17/04/2018 – Biogen Builds on Its 40-Year Legacy in Neuroscience with Presentation of Research from Its Portfolio of Medicines and Investigational Programs for Neurodegenerative Diseases; 13/03/2018 – CSL CEO Paul Perreault Calls on Industry to Improve Patients’ Access to Medicines; 28/03/2018 – KINGWORLD MEDICINES GROUP LTD 1110.HK – BOARD RECOMMENDED DISTRIBUTION OF A FINAL DIVIDEND OF HK3.43 CENTS PER SHARE; 23/04/2018 – EUROPEAN MEDICINES AGENCY VALIDATES TYPE Il VARIATION FOR MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH PEMETREXED (ALIMTA®) AND PLATINUM CHEMOTHERAPY AS FIRST-LINE THERAPY IN METASTATIC…

Coatue Management Llc increased its stake in Vera Bradley Inc (VRA) by 224.17% based on its latest 2018Q4 regulatory filing with the SEC. Coatue Management Llc bought 51,236 shares as the company’s stock declined 9.81% while stock markets rallied. The hedge fund held 74,092 shares of the consumer non-durables company at the end of 2018Q4, valued at $635,000, up from 22,856 at the end of the previous reported quarter. Coatue Management Llc who had been investing in Vera Bradley Inc for a number of months, seems to be bullish on the $402.46 million market cap company. The stock decreased 1.75% or $0.21 during the last trading session, reaching $11.78. About 201,599 shares traded. Vera Bradley, Inc. (NASDAQ:VRA) has declined 3.27% since April 16, 2018 and is downtrending. It has underperformed by 7.64% the S&P500. Some Historical VRA News: 14/03/2018 – VERA BRADLEY 4Q ADJ EPS 33C, EST. 32C; 02/04/2018 – Vera Bradley Presenting at Cowen Conference Tomorrow; 14/03/2018 Vera Bradley 4Q EPS 24c; 14/03/2018 – VERA BRADLEY SAYS COMP SALES CONTINUE TO BE NEGATIVELY IMPACTED BY Y-O-Y DECLINES IN STORE AND E-COMMERCE TRAFFIC; 14/03/2018 – Vera Bradley 4Q Rev $132M; 14/03/2018 – Vera Bradley Sees FY Rev $405M-$425M; 14/03/2018 – VERA BRADLEY INC VRA.O SEES FY 2019 SHR $0.35 TO $0.45; 16/03/2018 – Vera Bradley Closes Above 50-Day Moving Average: Technicals; 14/03/2018 – VERA BRADLEY INC VRA.O FY2019 SHR VIEW $0.47, REV VIEW $415.2 MLN — THOMSON REUTERS l/B/E/S; 14/03/2018 – VERA BRADLEY IN PACT WITH APPAREL PARTNERSHIP

Highvista Strategies Llc, which manages about $3.88 billion and $115.59M US Long portfolio, upped its stake in Vanguard Index Fds (VNQ) by 4,400 shares to 28,000 shares, valued at $2.09 million in 2018Q4, according to the filing.

Investors sentiment increased to 1.76 in 2018 Q4. Its up 0.68, from 1.08 in 2018Q3. It improved, as 23 investors sold MDCO shares while 36 reduced holdings. 38 funds opened positions while 66 raised stakes. 89.79 million shares or 2.48% more from 87.62 million shares in 2018Q3 were reported. Wolverine Asset Limited Liability Corp reported 3,513 shares. 61,377 were accumulated by Barclays Public Ltd Company. Amer International Grp Inc invested in 0% or 53,060 shares. Css Limited Liability Co Il holds 9,079 shares. Public Employees Retirement Association Of Colorado stated it has 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Comerica Bank invested in 103,304 shares. Greenlight Cap has invested 1.31% of its portfolio in The Medicines Company (NASDAQ:MDCO). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 4,372 shares. Tiaa Cref Mngmt Ltd owns 167,655 shares. Orbimed Limited Liability Corporation holds 0.02% or 54,600 shares. Charles Schwab Inv Mgmt Inc stated it has 363,711 shares or 0.01% of all its holdings. Louisiana State Employees Retirement invested in 0.03% or 24,716 shares. Millennium Limited Liability holds 0% or 136,106 shares. 335,000 were accumulated by Eventide Asset Mngmt Ltd. Prudential Financial holds 0% of its portfolio in The Medicines Company (NASDAQ:MDCO) for 107,052 shares.

Since November 16, 2018, it had 9 insider purchases, and 0 sales for $42.57 million activity. Cox Christopher T bought $2.01 million worth of stock. Another trade for 2,926 shares valued at $52,375 was bought by Timney Mark.

Analysts await The Medicines Company (NASDAQ:MDCO) to report earnings on April, 24. They expect $-0.35 EPS, up 56.25% or $0.45 from last year’s $-0.8 per share. After $-0.67 actual EPS reported by The Medicines Company for the previous quarter, Wall Street now forecasts -47.76% EPS growth.

More notable recent The Medicines Company (NASDAQ:MDCO) news were published by: Seekingalpha.com which released: “Medicines beats by $0.02 – Seeking Alpha” on February 27, 2019, also Livetradingnews.com with their article: “The Street’s Key Stock Analysts Research Reports – Live Trading News” published on March 29, 2019, Nasdaq.com published: “Monday 3/11 Insider Buying Report: MDCO, STBA – Nasdaq” on March 11, 2019. More interesting news about The Medicines Company (NASDAQ:MDCO) were released by: Streetinsider.com and their article: “Pre-Open Stock Movers 03/21: (GIII) (PTE) (CAG) Higher; (BIIB) (LQDA) (GES) Lower (more…) – StreetInsider.com” published on March 21, 2019 as well as 247Wallst.com‘s news article titled: “Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More – 24/7 Wall St.” with publication date: March 28, 2019.

Investors sentiment decreased to 1.57 in 2018 Q4. Its down 1.25, from 2.82 in 2018Q3. It is negative, as 26 investors sold VRA shares while 27 reduced holdings. 20 funds opened positions while 63 raised stakes. 23.63 million shares or 0.66% less from 23.79 million shares in 2018Q3 were reported. The California-based Assetmark has invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Morgan Stanley invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Citadel Advisors Limited Liability reported 215,394 shares. California Pub Employees Retirement Systems invested in 0% or 93,611 shares. Mason Street Limited owns 6,698 shares. State Board Of Administration Of Florida Retirement Sys invested 0% of its portfolio in Vera Bradley, Inc. (NASDAQ:VRA). Raymond James And invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Deutsche Bank Ag has invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Thrivent Financial For Lutherans stated it has 0% in Vera Bradley, Inc. (NASDAQ:VRA). State Of Tennessee Treasury Department invested in 21,720 shares or 0% of the stock. Ameriprise Fincl Incorporated has 344,664 shares. Connecticut-based Tudor Invest Et Al has invested 0.02% in Vera Bradley, Inc. (NASDAQ:VRA). Shell Asset Comm has 0.02% invested in Vera Bradley, Inc. (NASDAQ:VRA). Stone Ridge Asset Mgmt Limited Liability Company owns 94,659 shares or 0.05% of their US portfolio. Bancorp Of Mellon Corp stated it has 0% in Vera Bradley, Inc. (NASDAQ:VRA).

Vera Bradley, Inc. (NASDAQ:VRA) Institutional Positions Chart

Related Posts:

  • No Related Posts

Euronet Worldwide (EEFT) Holder New Amsterdam Partners Raised Its Stake by $1.34 Million as …

… 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop; …

The Medicines Company (NASDAQ:MDCO) Logo

Highvista Strategies Llc decreased its stake in Medicines Co (MDCO) by 12.64% based on its latest 2018Q4 regulatory filing with the SEC. Highvista Strategies Llc sold 33,900 shares as the company’s stock rose 20.76% with the market. The hedge fund held 234,340 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $4.49M, down from 268,240 at the end of the previous reported quarter. Highvista Strategies Llc who had been investing in Medicines Co for a number of months, seems to be less bullish one the $2.17 billion market cap company. The stock increased 0.51% or $0.15 during the last trading session, reaching $29.46. About 959,056 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 22.18% since April 4, 2018 and is downtrending. It has underperformed by 26.55% the S&P500. Some Historical MDCO News: 16/04/2018 – The medicines, which help unleash the immune system on cancer cells, were tested in patients with advanced lung cancer; 30/04/2018 – Homology Medicines Announces Upcoming Presentations on its Genetic Medicines Platform at the American Society of Gene & Cell Th; 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop; 28/03/2018 – Personalized Medicines Market 2016-2024: Targeted Therapeutics & Tests & Lab Services – Global Strategic Business Report 2018 – ResearchAndMarkets.com; 23/04/2018 – EUROPEAN MEDICINES AGENCY VALIDATES TYPE Il VARIATION FOR MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH PEMETREXED (ALIMTA®) AND PLATINUM CHEMOTHERAPY AS FIRST-LINE THERAPY IN METASTATIC; 08/05/2018 – ASTRAZENECA PLC AZN.L – EUROPEAN MEDICINES AGENCY (EMA) HAS APPROVED LYNPARZA (OLAPARIB) TABLETS; 24/04/2018 – Bormioli Pharma Addresses Drug Stability and Value-Added Medicines with Packaging Innovation; 11/03/2018 – Umer Raffat set up a call with $MDCO execs tomorrow. Focus is on $ESPR, $MDCO and $AMGN reactions after $REGN and $SNY scored on high-risk PCSK9 study – DON’T MISS:; 07/05/2018 – The Medicines Co Announces Inclisiran Data Showing Significant Reductions in Potentially Harmful Subtypes of Bad Cholesterol; 03/04/2018 – REGENERON PHARMACEUTICALS INC REGN.O – EUROPEAN MEDICINES AGENCY HAS ACCEPTED FOR REVIEW MARKETING AUTHORIZATION APPLICATION (MAA) FOR CEMIPLIMAB

New Amsterdam Partners Llc increased its stake in Euronet Worldwide Inc (EEFT) by 35.76% based on its latest 2018Q4 regulatory filing with the SEC. New Amsterdam Partners Llc bought 13,154 shares as the company’s stock rose 16.40% with the market. The institutional investor held 49,934 shares of the finance company at the end of 2018Q4, valued at $5.11 million, up from 36,780 at the end of the previous reported quarter. New Amsterdam Partners Llc who had been investing in Euronet Worldwide Inc for a number of months, seems to be bullish on the $7.37 billion market cap company. The stock increased 0.46% or $0.65 during the last trading session, reaching $141.98. About 963,302 shares traded or 87.18% up from the average. Euronet Worldwide, Inc. (NASDAQ:EEFT) has risen 65.22% since April 4, 2018 and is uptrending. It has outperformed by 60.85% the S&P500. Some Historical EEFT News: 15/05/2018 – Waddell & Reed Financial Inc. Exits Position in Euronet; 31/05/2018 – New Research Coverage Highlights Constellation Brands, Yintech Investment, EZCORP, Euronet Worldwide, Fidelity National Financi; 15/05/2018 – Capital Group Companies Buys New 1.8% Position in Euronet; 21/03/2018 – Euronet Closes Above 50-Day Moving Average: Technicals; 24/04/2018 – Euronet Worldwide 1Q EPS 49c; 25/04/2018 – Euronet acquires lnnova Tax Free Group and Expands its Merchant Acquiring Offering in Europe; 24/04/2018 – Euronet Worldwide 1Q Adj EPS 73c; 24/04/2018 – EURONET 1Q ADJ CASH EPS 73C, EST. 73C; 19/03/2018 – Euronet Conference Call Scheduled By Northland for Mar. 27; 25/04/2018 – EURONET BUYS INNOVA TAX FREE GROUP, EXPANDS MERCHANT ACQUIRING

Since October 23, 2018, it had 0 insider purchases, and 9 insider sales for $31.12 million activity. The insider NEWMAN JEFFREY B sold 5,000 shares worth $560,800. Brown Michael J sold $3.65M worth of stock or 32,667 shares. $6.09 million worth of Euronet Worldwide, Inc. (NASDAQ:EEFT) was sold by Caponecchi Kevin J.

More notable recent Euronet Worldwide, Inc. (NASDAQ:EEFT) news were published by: Seekingalpha.com which released: “Euronet Worldwide to redeem convertible notes due 2044 – Seeking Alpha” on March 18, 2019, also Nasdaq.com with their article: “Why Hold Strategy is Apt for PRA Group in Your Portfolio – Nasdaq” published on March 15, 2019, Nasdaq.com published: “PRA Group (PRAA) Buys Resurgent Holdings’ Canadian Business – Nasdaq” on March 05, 2019. More interesting news about Euronet Worldwide, Inc. (NASDAQ:EEFT) were released by: Nasdaq.com and their article: “Western Union, Thunes Tie Up to Boost Digital Money Transfer – Nasdaq” published on March 19, 2019 as well as Nasdaq.com‘s news article titled: “Mastercard (MA) to Acquire Ethoca to Enhance Cyber Strategy – Nasdaq” with publication date: March 13, 2019.

Investors sentiment increased to 1.37 in 2018 Q4. Its up 0.17, from 1.2 in 2018Q3. It is positive, as 16 investors sold EEFT shares while 93 reduced holdings. 59 funds opened positions while 90 raised stakes. 47.25 million shares or 0.62% less from 47.55 million shares in 2018Q3 were reported. Millrace Asset Group Inc Inc stated it has 1.41% of its portfolio in Euronet Worldwide, Inc. (NASDAQ:EEFT). Neuberger Berman Limited Liability Co reported 2,500 shares stake. Cwm Ltd Liability accumulated 0% or 294 shares. Aristotle Capital Boston Ltd Llc has invested 2.25% of its portfolio in Euronet Worldwide, Inc. (NASDAQ:EEFT). 73,809 were accumulated by Credit Suisse Ag. Great Lakes Advsr Ltd Llc reported 141,614 shares stake. Bnp Paribas Arbitrage has invested 0% in Euronet Worldwide, Inc. (NASDAQ:EEFT). Gsa Capital Prtnrs Llp holds 13,000 shares. United Kingdom-based Jupiter Asset Management has invested 0.57% in Euronet Worldwide, Inc. (NASDAQ:EEFT). Renaissance Group Limited Liability Corporation stated it has 0.03% in Euronet Worldwide, Inc. (NASDAQ:EEFT). Van Berkom Assoc Inc has 3.11% invested in Euronet Worldwide, Inc. (NASDAQ:EEFT) for 861,013 shares. 67,987 were reported by Axiom Int Invsts Limited Liability Co De. Swiss Comml Bank holds 90,200 shares. Clark has 46,943 shares for 0.13% of their portfolio. Moreover, State Of Wisconsin Invest Board has 0% invested in Euronet Worldwide, Inc. (NASDAQ:EEFT).

New Amsterdam Partners Llc, which manages about $303.74M US Long portfolio, decreased its stake in Arrow Electronics Inc (NYSE:ARW) by 8,042 shares to 64,841 shares, valued at $4.47 million in 2018Q4, according to the filing. It also reduced its holding in Mks Instrument Inc (NASDAQ:MKSI) by 55,656 shares in the quarter, leaving it with 3,125 shares, and cut its stake in Littelfuse Inc (NASDAQ:LFUS).

Highvista Strategies Llc, which manages about $3.88 billion and $115.59 million US Long portfolio, upped its stake in Vanguard Index Fds (VNQ) by 4,400 shares to 28,000 shares, valued at $2.09M in 2018Q4, according to the filing.

Investors sentiment increased to 1.76 in 2018 Q4. Its up 0.68, from 1.08 in 2018Q3. It improved, as 23 investors sold MDCO shares while 36 reduced holdings. 38 funds opened positions while 66 raised stakes. 89.79 million shares or 2.48% more from 87.62 million shares in 2018Q3 were reported. Moreover, Pinebridge Limited Partnership has 0.02% invested in The Medicines Company (NASDAQ:MDCO) for 54,275 shares. Panagora Asset reported 173,417 shares stake. Fosun Ltd stated it has 0.04% in The Medicines Company (NASDAQ:MDCO). Cim Mangement Inc has 0.12% invested in The Medicines Company (NASDAQ:MDCO). South Dakota Council, South Dakota-based fund reported 13,600 shares. Fincl Bank Of America Corporation De invested in 1.70 million shares. Tci Wealth Advsrs invested in 50 shares or 0% of the stock. Bank & Trust Of Ny Mellon Corporation reported 0% stake. Guggenheim Cap Ltd reported 88,407 shares or 0.01% of all its holdings. Rhenman & Prtn Asset Mgmt Ab has invested 0.3% of its portfolio in The Medicines Company (NASDAQ:MDCO). Css Ltd Liability Il holds 9,079 shares or 0.01% of its portfolio. Pictet Asset Ltd invested in 0% or 65,100 shares. Greenlight Cap reported 948,800 shares. Elk Creek Prns Lc reported 763,154 shares. 100,977 are held by Alliancebernstein Limited Partnership.

Analysts await The Medicines Company (NASDAQ:MDCO) to report earnings on April, 24. They expect $-0.35 EPS, up 56.25% or $0.45 from last year’s $-0.8 per share. After $-0.67 actual EPS reported by The Medicines Company for the previous quarter, Wall Street now forecasts -47.76% EPS growth.

More notable recent The Medicines Company (NASDAQ:MDCO) news were published by: 247Wallst.com which released: “Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More – 24/7 Wall St.” on March 28, 2019, also Nasdaq.com with their article: “Monday 3/11 Insider Buying Report: MDCO, STBA – Nasdaq” published on March 11, 2019, Nasdaq.com published: “Will Medicines Co. (MDCO) Report Negative Q4 Earnings? What You Should Know – Nasdaq” on February 13, 2019. More interesting news about The Medicines Company (NASDAQ:MDCO) were released by: Nasdaq.com and their article: “Medicines Co. (MDCO) Up 12.9% Since Last Earnings Report: Can It Continue? – Nasdaq” published on March 29, 2019 as well as Nasdaq.com‘s news article titled: “Medicines Company (MDCO) Q4 Loss Widens, Inclisiran in Focus – Nasdaq” with publication date: February 28, 2019.

Since November 16, 2018, it had 9 buys, and 0 insider sales for $42.57 million activity. 10,000 shares were bought by DENNER ALEXANDER J, worth $178,900. 50,300 shares were bought by Cox Christopher T, worth $992,419.

Euronet Worldwide, Inc. (NASDAQ:EEFT) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

As Commvault Systems (CVLT) Valuation Declined, Acadian Asset Management Has Boosted Its …

Acadian Asset Management Llc increased its stake in Commvault Systems Inc (CVLT) by 1775.85% based on its latest 2018Q3 regulatory filing with …

Commvault Systems, Inc. (NASDAQ:CVLT) Logo

Highvista Strategies Llc increased its stake in Mobile Telesystems Pjsc (MBT) by 325.32% based on its latest 2018Q3 regulatory filing with the SEC. Highvista Strategies Llc bought 50,100 shares as the company’s stock declined 5.99% with the market. The hedge fund held 65,500 shares of the telecommunications equipment company at the end of 2018Q3, valued at $559,000, up from 15,400 at the end of the previous reported quarter. Highvista Strategies Llc who had been investing in Mobile Telesystems Pjsc for a number of months, seems to be bullish on the $7.53 billion market cap company. The stock decreased 1.93% or $0.16 during the last trading session, reaching $8.15. About 1.44 million shares traded. Public Joint-Stock Company Mobile TeleSystems (NYSE:MBT) has declined 22.71% since January 28, 2018 and is downtrending. It has underperformed by 22.71% the S&P500. Some Historical MBT News: 07/03/2018 – MOBILE TELESYSTEMS STAKE IN OZON.RU TO INCREASE TO 13.7%; 19/03/2018 – MOBILE TELESYSTEMS 4Q REV. 117B RUBLES, EST. 115B; 19/03/2018 – Russia’s MTS expects slight revenue growth in 2018; 07/03/2018 – Russia’s MTS to spend $30 mln on Ozon stake increase; 20/03/2018 – MTS MBT.N : VTB CAPITAL LOWERS TO HOLD FROM BUY FOR DRS; 07/03/2018 MOBILE TELESYSTEMS TO INCREASE STAKE IN OZON.RU: IFX; 23/05/2018 – MOBILE TELESYSTEMS 1Q REVENUE 107.9B RUBLES; 19/03/2018 – MOBILE TELESYSTEMS SEES 2018 DIVS AT ABOUT 52B RUBLES; 25/05/2018 – MOBILE TELESYSTEMS ANNOUNCES RESTRUCTURING OF 35B RUB OF LOANS; 21/03/2018 – Rosneft says agreement with Sistema fully implemented -RIA

Acadian Asset Management Llc increased its stake in Commvault Systems Inc (CVLT) by 1775.85% based on its latest 2018Q3 regulatory filing with the SEC. Acadian Asset Management Llc bought 79,416 shares as the company’s stock declined 18.74% with the market. The institutional investor held 83,888 shares of the technology company at the end of 2018Q3, valued at $5.87 million, up from 4,472 at the end of the previous reported quarter. Acadian Asset Management Llc who had been investing in Commvault Systems Inc for a number of months, seems to be bullish on the $2.83B market cap company. The stock decreased 1.96% or $1.22 during the last trading session, reaching $61.06. About 441,989 shares traded or 15.21% up from the average. Commvault Systems, Inc. (NASDAQ:CVLT) has risen 4.69% since January 28, 2018 and is uptrending. It has outperformed by 4.69% the S&P500. Some Historical CVLT News: 03/04/2018 – The County of San Mateo Selects Commvault HyperScale™ Appliances to Simplify Hybrid Cloud Data Management; 10/04/2018 – Commvault Innovates With New Proactive Customer Support Framework & Announces Seventh Consecutive Year Of Beating Industry Aver; 02/04/2018 – Elliott Management Targets Board Overhaul at Commvault; 10/04/2018 – Commvault lnnovates With New Proactive Customer Support Framework & Announces Seventh Consecutive Year Of Beating Industry Averages In Customer Support Satisfaction; 02/04/2018 – ELLIOTT MANAGEMENT SAYS BELIEVE COMMVAULT SHOULD IMMEDIATELY INITIATE A COMPREHENSIVE OPERATIONAL REVIEW LED BY BOARD; 22/05/2018 – Commvault Extends Data Management Capabilities For Microsoft Office 365; 01/05/2018 – CVLT NEW GOVERNANCE INITIATIVES RELATES TO PACT WITH ELLIOTT; 01/05/2018 – CommVault Systems: New Committee to Conduct Cap Return Review; 11/04/2018 – Commvault Expands Microsoft Azure Stack Integration; 29/03/2018 – Tintri and Commvault Automate Data Protection for Customer Applications

Highvista Strategies Llc, which manages about $3.88 billion and $214.42 million US Long portfolio, decreased its stake in Transdigm Group Inc (NYSE:TDG) by 2,300 shares to 12,730 shares, valued at $4.74 million in 2018Q3, according to the filing. It also reduced its holding in Sba Communications Corp New by 2,300 shares in the quarter, leaving it with 29,297 shares, and cut its stake in Aetna Inc New (NYSE:AET).

More notable recent Public Joint-Stock Company Mobile TeleSystems (NYSE:MBT) news were published by: Seekingalpha.com which released: “Mobile TeleSystems: A Cautious Buy – Seeking Alpha” on August 17, 2018, also Seekingalpha.com with their article: “Mobile TeleSystems: Stable Business With Upside Potential – Seeking Alpha” published on September 24, 2018, Fool.com published: “Is Mobile TeleSystems Stock a Buy? 1 Analyst Thinks So – Motley Fool” on May 17, 2018. More interesting news about Public Joint-Stock Company Mobile TeleSystems (NYSE:MBT) were released by: Seekingalpha.com and their article: “MBT Gets Political – Seeking Alpha” published on July 17, 2017 as well as Seekingalpha.com‘s news article titled: “MBT -2.2% as lawmakers urge sanctioning Russian tycoon – Seeking Alpha” with publication date: June 22, 2018.

Among 10 analysts covering Mobile TeleSystems (NYSE:MBT), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. Mobile TeleSystems had 20 analyst reports since August 19, 2015 according to SRatingsIntel. The stock has “Buy” rating by Citigroup on Wednesday, August 19. Citigroup downgraded it to “Neutral” rating and $8 target in Thursday, March 10 report. The stock has “Overweight” rating by Morgan Stanley on Monday, January 22. Standpoint Research downgraded the shares of MBT in report on Friday, April 7 to “Hold” rating. The stock of Public Joint-Stock Company Mobile TeleSystems (NYSE:MBT) earned “Hold” rating by Deutsche Bank on Thursday, March 24. The stock of Public Joint-Stock Company Mobile TeleSystems (NYSE:MBT) has “Buy” rating given on Wednesday, July 26 by J.P. Morgan. Citigroup upgraded the shares of MBT in report on Monday, November 21 to “Buy” rating. The stock has “Hold” rating by Raiffeisen Centrobank on Friday, October 21. The stock of Public Joint-Stock Company Mobile TeleSystems (NYSE:MBT) earned “Hold” rating by HSBC on Thursday, March 24. The stock has “Hold” rating by Deutsche Bank on Wednesday, December 6.

More notable recent Commvault Systems, Inc. (NASDAQ:CVLT) news were published by: Seekingalpha.com which released: “Commvault -2.4% on Q1 misses, new CEO search – CommVault Systems, Inc. (NASDAQ:CVLT) – Seeking Alpha” on May 01, 2018, also Nasdaq.com with their article: “Sportsman’s Warehouse Holdings, Inc. Appoints Martha Bejar to Its Board of Directors – Nasdaq” published on January 14, 2019, 247Wallst.com published: “Why Elliott Management Wants Its Say (and Profit) in Commvault – 24/7 Wall St.” on April 02, 2018. More interesting news about Commvault Systems, Inc. (NASDAQ:CVLT) were released by: Seekingalpha.com and their article: “CommVault Systems, Inc. 2019 Q2 – Results – Earnings Call Slides – Seeking Alpha” published on October 30, 2018 as well as Nasdaq.com‘s news article titled: “Oversold Conditions For CommVault Systems (CVLT) – Nasdaq” with publication date: June 27, 2018.

Since August 14, 2018, it had 0 buys, and 2 selling transactions for $68,715 activity. $8,730 worth of Commvault Systems, Inc. (NASDAQ:CVLT) was sold by Merrill Gary.

Acadian Asset Management Llc, which manages about $65.15B and $24.21 billion US Long portfolio, decreased its stake in Best Buy Inc (NYSE:BBY) by 60,680 shares to 4,406 shares, valued at $350,000 in 2018Q3, according to the filing. It also reduced its holding in Lockheed Martin Corp (NYSE:LMT) by 70,994 shares in the quarter, leaving it with 7,272 shares, and cut its stake in Bancorp Inc Del (NASDAQ:TBBK).

Among 15 analysts covering Commvault Systems Inc. (NASDAQ:CVLT), 9 have Buy rating, 0 Sell and 6 Hold. Therefore 60% are positive. Commvault Systems Inc. had 48 analyst reports since July 29, 2015 according to SRatingsIntel. MUFG Securities Americas Inc downgraded it to “Hold” rating and $57.0 target in Tuesday, October 24 report. Mizuho maintained it with “Buy” rating and $60 target in Friday, September 9 report. The firm has “Buy” rating by Jefferies given on Wednesday, July 27. The firm earned “Buy” rating on Friday, September 1 by Jefferies. On Wednesday, October 31 the stock rating was downgraded by KeyBanc Capital Markets to “Sector Weight”. Sterne Agee CRT downgraded Commvault Systems, Inc. (NASDAQ:CVLT) on Monday, January 18 to “Neutral” rating. The stock has “Buy” rating by Mizuho on Wednesday, July 29. Jefferies maintained Commvault Systems, Inc. (NASDAQ:CVLT) on Wednesday, September 14 with “Buy” rating. The firm has “Buy” rating given on Tuesday, November 14 by Wells Fargo. The stock of Commvault Systems, Inc. (NASDAQ:CVLT) earned “Buy” rating by KeyBanc Capital Markets on Tuesday, October 24.

Investors sentiment decreased to 0.87 in 2018 Q3. Its down 0.12, from 0.99 in 2018Q2. It worsened, as 22 investors sold CVLT shares while 75 reduced holdings. 29 funds opened positions while 55 raised stakes. 36.59 million shares or 0.70% less from 36.85 million shares in 2018Q2 were reported. Bnp Paribas Arbitrage Sa accumulated 7,767 shares. Pnc Serv Gp Inc holds 0% of its portfolio in Commvault Systems, Inc. (NASDAQ:CVLT) for 5,681 shares. Meeder Asset, Ohio-based fund reported 12,641 shares. Eagle Asset Mgmt holds 0.09% in Commvault Systems, Inc. (NASDAQ:CVLT) or 280,731 shares. Fort Washington Invest Advisors Oh owns 283,176 shares or 0.2% of their US portfolio. Aqr Capital Mngmt Ltd Co stated it has 0% in Commvault Systems, Inc. (NASDAQ:CVLT). New Mexico Educational Retirement Board invested 0.03% in Commvault Systems, Inc. (NASDAQ:CVLT). Fmr Llc owns 2.30M shares. Gemmer Asset Management Ltd Liability Co accumulated 74 shares. Systematic Mgmt Ltd Partnership has invested 0.01% in Commvault Systems, Inc. (NASDAQ:CVLT). Morgan Stanley, a New York-based fund reported 126,453 shares. American Management reported 0.52% of its portfolio in Commvault Systems, Inc. (NASDAQ:CVLT). Cubist Systematic Strategies Lc holds 10,014 shares or 0.04% of its portfolio. Northern Trust Corp reported 0.01% in Commvault Systems, Inc. (NASDAQ:CVLT). Metropolitan Life Ins New York holds 12,724 shares or 0.02% of its portfolio.

Commvault Systems, Inc. (NASDAQ:CVLT) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts